lamellarin-d and fosbretabulin

lamellarin-d has been researched along with fosbretabulin* in 1 studies

Other Studies

1 other study(ies) available for lamellarin-d and fosbretabulin

ArticleYear
Novel hybrids from lamellarin D and combretastatin A 4 as cytotoxic agents.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:1

    A new series of hybrids of lamellarin D and combretastatin A 4, 1,2-diphenyl-5,6-dihydropyrrolo [2,1-a] isoquinolines, were designed as cytotoxic agents based on principles of combination in medicinal chemistry and taking the parent compounds' different anti-proliferative mechanisms into consideration. Twenty-two novel hybrids were synthesized through a convenient route, with a key step of core pyrrole formation and evaluated for their anti-proliferative activities in vitro against K-562, A-549, SMMC-7721, SGC-7901 and HCT-116 cancer cell lines. The results showed that some hybrids had good anti-proliferative activities in low IC50 ranges.

    Topics: Cell Line, Tumor; Cell Proliferation; Coumarins; Cytotoxins; Heterocyclic Compounds, 4 or More Rings; Humans; Inhibitory Concentration 50; Isoquinolines; Models, Molecular; Molecular Conformation; Stilbenes

2010